CPT1A and obesity due to melanocortin 4 receptor deficiency: It has been found that CPT1 plays a protective role against fatty acid-induced adipocyte dysfunction suggesting that pharmacological activation of CPT1 might represent a promising strategy for the prevention and treatment of obesity related metabolic diseases44.